Search Results for: Poor

March 18, 2025March 18, 2025

Poorer survival for patients with inflammatory arthritis treated with immune checkpoint inhibitors for melanoma.

Melanoma Literature

Publication date: Mar 16, 2025 Patients with inflammatory arthritis treated with immune checkpoint inhibitors (ICIs) for melanoma face unique challenges, including disease flares and reduced treatment efficacy. Evidence on the ... Read more

March 12, 2025March 12, 2025

Late pandemic COVID-19 positivity at the time of thrombectomy is associated with poor outcomes and tandem carotid pathology.

Coronavirus Literature

Publication date: Mar 11, 2025 COVID-19 is an independent risk factor for ischemic stroke. Studies from early in the pandemic show increased rates of unfavorable recanalization, poor outcomes, and mortality ... Read more

March 12, 2025March 12, 2025

Poor mental health and its impact on academic outcomes in university students before and during the COVID-19 pandemic: analysis of routine service data.

Coronavirus Literature

Publication date: Mar 11, 2025 There is an urgent need to understand explanatory factors of poor mental health before (pre-) and during (peri-) the COVID-19 pandemic in university students, especially ... Read more

March 8, 2025March 8, 2025

Translating Genetics into Tissue: Inflammatory Cytokine-Producing TAMs and PD-L1 Tumor Expression as Poor Prognosis Factors in Cutaneous Melanoma

Melanoma News

Publication date: Mar 06, 2025 Translating Genetics into Tissue: Inflammatory Cytokine-Producing TAMs and PD-L1 Tumor Expression as Poor Prognosis Factors in Cutaneous Melanoma PDF Concepts Keywords Cutaneous Cutaneous Poor Cytokine ... Read more

March 6, 2025March 6, 2025

Inpatient ICI Treatment Produces Poor Outcomes, Data Suggest

Melanoma News

Publication date: Mar 06, 2025 We found that patients who received IP ICI therapy for advanced malignancies had generally poor clinical outcomes with limited survival and high rates of IP ... Read more

March 4, 2025March 4, 2025

riSCC: A personalized risk model for the development of poor outcomes in cutaneous squamous cell carcinoma.

Melanoma Literature

Publication date: Feb 28, 2025 Cutaneous squamous cell carcinoma (CSCC) is a prevalent disease for which improved risk stratification strategies are needed. To develop a novel prognostic model (herein “riSCC”) ... Read more

March 1, 2025March 1, 2025

The predictive value of the LDH-albumin ratio on poor clinical course and mortality in COVID-19 patients: A single-center study.

Coronavirus Literature

Publication date: Feb 28, 2025 There are studies evaluating the association of serum lactate dehydrogenase (LDH) and albumin levels with mortality in COVID-19 patients. The aim of our study was ... Read more

February 22, 2025February 22, 2025

Are children and adolescents living with HIV in Europe and South Africa at higher risk of SARS-CoV-2 and poor COVID-19 outcomes?

Coronavirus Literature

Publication date: Feb 21, 2025 Open Access PDF Concepts Keywords Africa Adolescents Epidemiol Africa Europe Cov Hiv Covid Poor Epidemiol Europe Higher Hiv Infect Living Outcomes Poor Risk Sars South ... Read more

February 21, 2025February 21, 2025

Elevated Neutrophil-to-Lymphocyte Ratio Correlates With Liver Metastases and Poor Immunotherapy Response in Stage IV Melanoma.

Melanoma Literature

Publication date: Feb 01, 2025 Immune checkpoint inhibition (ICI) has revolutionized treatment for metastasized melanoma, but many patients remain unresponsive. Concerning potential adverse events, reliable biomarkers to predict ICI response ... Read more

February 21, 2025February 21, 2025

Low muscle mass as a poor prognostic factor in patients with advanced melanoma.

Melanoma Literature

Publication date: Feb 18, 2025 Low muscle mass is associated with poor immune checkpoint inhibitor (ICI) efficacy in patients with melanoma; however, whether this is true in all populations remains ... Read more